RxDoctor Payments Data

Ginger Kenney, PA

Physician Assistant · Sanford, NCNPI 1740646777

Payments from drug & device makers

$1,247in general payments, 2019–2025

Across 70 payments — averaging $17.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$291
  • AbbVie$274
  • Kowa Pharmaceuticals America, Inc.$131
  • Almatica Pharma LLC$113
  • Otsuka America Pharmaceutical, Inc.$109
  • Alkermes, Inc.$50
  • plus $279 from 10 others

What the payments were for

  • Food & beverage$1,247100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,247 in reported general payments places this provider in the 70th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$26,440
Medicare patients
113
Services billed
667

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide27$29,936
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$15,679
MounjaroTirzepatide15$14,695
Xigduo XrDapaglifloz Propaned/Metformin16$10,782
Breo ElliptaFluticasone/Vilanterol13$10,383
XareltoRivaroxaban12$10,222
EliquisApixaban19$7,634
Tresiba Flextouch U-200Insulin Degludec13$7,596
LinzessLinaclotide11$7,557
Spiriva RespimatTiotropium Bromide12$6,724
Lidocaine12$3,031
Albuterol Sulfate HfaAlbuterol Sulfate54$2,190
ValacyclovirValacyclovir Hcl15$1,525
Rosuvastatin Calcium32$935
Ventolin HfaAlbuterol Sulfate14$875

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$43$29,93627 claims
GSKTrelegy Ellipta, Breo Ellipta$43$26,06126 claims
Lilly USA, LLCMounjaro$43$14,69515 claims
Johnson & JohnsonXarelto$24$10,22212 claims
AbbVieLinzess$274$7,55711 claims
Almatica Pharma LLCSertraline Hcl$113$23111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Sanford

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →